Refining bone structure for gum defects around teeth

ISRCTN ISRCTN81861876
DOI https://doi.org/10.1186/ISRCTN81861876
Secondary identifying numbers PS2019009
Submission date
23/11/2023
Registration date
28/11/2023
Last edited
06/03/2024
Recruitment status
No longer recruiting
Overall study status
Ongoing
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Gum problems in the back of your mouth can come with issues like not enough protective gum tissue, shallow spaces between your teeth and cheeks, and unusual tissue connections. When all these oral issues happen at once, fixing them and getting good results for covering exposed tooth roots becomes more challenging. So, it's crucial to carefully choose the right surgical method.

While methods like moving existing tissue and creating a tunnel are well-supported by science, a different technique called apical buccal access (ABA) might have some unique benefits. Adding a special kind of biomaterial called allogeneic cortical lamina to the ABA technique could be a promising solution for combined bone and gum problems.

Our main goal in this study is to check how well this approach works for treating multiple gum recessions.

Who can participate?
Adults over 18 years, with several recessions in the gums near the cheek, and not enough tough gum tissue or depth between the teeth and cheek to keep things healthy. Also, when we look at a special type of X-ray called CBCT, the outer layer of the bone (cortex) is less than 1mm thick.

What does the study involve?
The study does not involve anything else than the treatment of the osseous-mucogingival defect and the routine follow up visits that we perform with or without participating in the study.

What are the possible benefits and risks of participating?
The benefit is that the osseous-mucogingival defect around their teeth will be treated and there is no risk of participating in the study

Where is the study run from?
CLINICA ORTIZ-VIGON (Spain)

When is the study starting and how long is it expected to run for?
September 2019 to September 2025

Who is funding the study?
Arrow Development SL (Spain)

Who is the main contact?
Dr Alberto Ortiz-Vigón, alberto@ortizvigon.com
Dr Erik Regidor, erik@ortizvigon.com

Contact information

Dr Erik Regidor Correa
Public, Scientific, Principal Investigator

Alameda Urquijo nº 2 - 7ª planta
Bilbao
48008
Spain

ORCiD logoORCID ID 0000-0003-3338-6379
Phone +34 662025988
Email erik@ortizvigon.com
Dr Alberto Ortiz-Vigón
Public, Scientific

Alameda Urquijo nº 2 - 7ª planta
Bilbao
48008
Spain

ORCiD logoORCID ID 0000-0002-1863-5907
Phone +34 944158902
Email alberto@ortizvigon.com

Study information

Study designProspective cohort study
Primary study designObservational
Secondary study designCohort study
Study setting(s)Dental clinic
Study typeTreatment
Participant information sheet No participant information sheet available
Scientific titleAllogeneic cortical lamina with apical buccal access for combined osseous & mucogingival defects around multiple adjacent teeth
Study objectivesThe apical buccal access technique combined with a demineralized cortical lamina without modifying the critical zone of the interdental papillae allows adequate root coverage results without compromising vascularization, while achieving an increase in keratinized gingiva and depth, vestibule reducing post-surgical morbidity and intervention time.
Ethics approval(s)

Approved 15/05/2019, Basque Country local ethics committee (Donostia-San Sebastián, 1, Vitoria, 01010, Spain; +34 945 019 303; ceic.eeaa@euskadi.eus), ref: PS2019009

Health condition(s) or problem(s) studiedMultiple vestibular gingival recessions with insufficient keratinized gingiva or vestibule depth for proper maintenance of the teeth. In addition, it must present a cortex less than 1mm on the CBCT.
InterventionFirst patients coming to periodontal maintenance will be examined. Patients with combined osseous-mucogingival defects around multiple adjacent teeth will be identified in a preliminary exam. In this visit, clinical and radiographic variables will be recorded. Then, the surgical procedure will be performed with allogeneic bone lamina and apical buccal access surgical design. Sutures at 2 weeks will be removed. Follow up visits will be at 3, 6 and 12 months. Periodontal maintenance therapy will be conducted at 6 and 12 months and during these visits, clinical and radiographic variables will be recorded. After 12 months of follow up the study will be finished.

Surgical procedure:
Buccal apical access flap for the treatment of gingival recessions with Cortiflex® demineralized cortical lamina. DIZG Cortiflex® (allogeneic cortical lamina). In combination with DIZG Cortico-Cancellous Particulate (Cortico-Cancellous Bone 50:50 FDBA Particulate Allograft) for horizontal bone augmentation.

Intervention typeProcedure/Surgery
Primary outcome measureAverage recession reduction measured with manual periodontal probe (Hu-Friedy CP15) at baseline, 6 and 12 months. Furthermore, intraoral scan will be recorded.
Secondary outcome measures1. Complete root coverage measured with manual periodontal probe (Hu-Friedy CP15) at baseline, 6 and 12 months. Furthermore, intraoral scan will be recorded.
2.. Changes in keratinized mucosa measured with manual periodontal probe (Hu-Friedy CP15) at baseline, 6 and 12 months. Furthermore, intraoral scan will be recorded.
3. Changes in vestibulum depth measured with manual periodontal probe (Hu-Friedy CP15) at baseline, 6 and 12 months. Furthermore, intraoral scan will be recorded.
4. Average reduction of the recession measured with manual periodontal probe (Hu-Friedy CP15) at baseline, 6 and 12 months. Furthermore, intraoral scan will be recorded.
Overall study start date01/09/2019
Completion date01/09/2025

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit90 Years
SexBoth
Target number of participants15
Total final enrolment15
Key inclusion criteria1. Informed consent after detailed information
2. Adults at least 18 years of age
3. Patients with multiple recessions (≥2 teeth) type III with shallow vestibule depth and keratinized gingiva that do not include molars, and may be in the upper and lower jaw.
4. Patients who, in the three-dimensional x-ray, present a vestibular cortex less than 1mm thick
5. Healthy or periodontally treated patients
6. Systemically healthy or with completely controlled or stabilized diseases. A medical report will be requested that confirms the stabilization of the specific disease.
7. General plaque control (FMPS) ≤ 25% (O'Leary et al 1972)
Key exclusion criteria1. Pregnant or breastfeeding patients
2. Uncontrolled medical conditions
3. Uncontrolled periodontal disease
4. Patients treated with any medication that affects gingival conditions such as causing hyperplasia
5. Alcohol and/or drug abuse
6. Do not sign informed consent
7. Despite having root recessions, it presents a cortex greater than 1mm in the 3D CBCT and therefore another type of technique is considered necessary.
Date of first enrolment01/09/2019
Date of final enrolment01/05/2024

Locations

Countries of recruitment

  • Spain

Study participating centre

Clínica Ortiz-Vigón
C/ alameda urquijo 2 7º floor
Bilbao
48008
Spain

Sponsor information

Arrow Development S.L.
Research organisation

C/alameda Mazarredo 22 11B
Bilbao
48009
Spain

Phone +34 944 15 89 02
Email cursos@ortizvigon.com

Funders

Funder type

Industry

Arrow Development SL

No information available

Results and Publications

Intention to publish date01/09/2025
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot expected to be made available
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal
IPD sharing planNot expected to be made available

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol file 24/11/2023 No No

Additional files

44634 protocol.pdf

Editorial Notes

06/03/2024: The Sponsor's email address was corrected.
24/11/2023: Trial's existence confirmed by Basque Country local ethics committee.